These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 6010440)

  • 1. [Effect of 5-n-butyl-l-cyclohexyl-2,4,6-trioxoperhydropyrimidine (BCP) on bacterial infection].
    Kondo M; Yamasaki T; Tsuchiya K
    Nihon Saikingaku Zasshi; 1966 Dec; 21(12):715-8. PubMed ID: 6010440
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of 5-n-butyl-l-cyclohexyl-2,4,6-trioxoperhydropyrimidine (BCP) on antibody formation].
    Kondo M; Tsuchiya K
    Nihon Saikingaku Zasshi; 1966 Oct; 21(10):629-32. PubMed ID: 6009584
    [No Abstract]   [Full Text] [Related]  

  • 3. In vivo antibacterial activity of diaveridine-sulfonamide combinations.
    Carroll PT; Robb CA; Tippett LO; Langston JB
    Invest Urol; 1971 Jul; 9(1):21-4. PubMed ID: 4935215
    [No Abstract]   [Full Text] [Related]  

  • 4. [An anti-phlogistic effect of BCP (5-n-butyl-1-cyclohexyl-2,4,6-trioxoperhydropyrimidine) on experimentally induced ocular inflammation].
    Asayama R; Tsukahara I; Sakaue E; Fukuchi S; Suga K
    Nihon Ganka Kiyo; 1966 Feb; 17(2):89-101. PubMed ID: 6006623
    [No Abstract]   [Full Text] [Related]  

  • 5. [A clinical study on anti-inflammatory effect of BCP (5-n-butyl-1-cyclohexyl-2,4,6-trioxoperhydropyrimidine)].
    Asayama R; Tsukahara I; Sakaue E; Fukuchi S; Suga K
    Nihon Ganka Kiyo; 1966 Feb; 17(2):102-6. PubMed ID: 6006605
    [No Abstract]   [Full Text] [Related]  

  • 6. [Chemotherapeutic study of ampicillin in experimental infections].
    Petrova MA; Berezina EK; Chavdarova VB
    Antibiotiki; 1968 Sep; 13(9):815-20. PubMed ID: 4884475
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pharmacological studies on 5-n-butyl-1-cyclohexyl-2,4,6-trioxoperhydropyrimidine (BCP) as an anti-inflammatory agent].
    Fujimura H; Tsurumi A; Hayashi M; Ushijima M; Esaki S
    Nihon Yakurigaku Zasshi; 1967 Mar; 63(2):43-86. PubMed ID: 6069249
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experiences with trimethoprim-sulfamethoxazole in the chemotherapy of bacterial infections].
    Tauchnitz C
    Z Gesamte Inn Med; 1970 Aug; 25(16):734-8. PubMed ID: 4941224
    [No Abstract]   [Full Text] [Related]  

  • 9. [Chemotherapeutic activity of acetoxymethyl derivatives of di-N-oxides of quinoxaline in acute bacterial infections].
    Padeĭskaia EN; Pershin GN; Belozerova KA
    Farmakol Toksikol; 1966; 29(6):702-9. PubMed ID: 4876657
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antibacterial activity in vitro and in vivo of the trimethoprim-sulphamethoxazole combination].
    Renzini G; Ravagnan G; Bormioli P; D'Alessandro A
    Antibiotica; 1969 Dec; 7(4):250-68. PubMed ID: 5004706
    [No Abstract]   [Full Text] [Related]  

  • 11. [Chemotherapeutic action of quinozaline derivatives and N-oxides of quinoxaline in acute bacterial infections].
    Padeĭskaia EN; Elina AS; Pershin GN; Tsyrul'nikova LG; Belozerova KA
    Farmakol Toksikol; 1967; 30(5):617-26. PubMed ID: 4877416
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on the metabolic fate and the pharmacokinetics of 5-n-butyl-1-cyclohexyl-2,4,6-trioxoperhydropyrimidine (BCP) in man. II. Determination of BCP and its metabolite, 1-cyclohexyl-5-(3-hydroxybutyl)-2,4,6-trioxoperhydropyrimidine by ultraviolet absorption method.
    Yashiki T; Kondo T; Uda Y; Mima H
    Chem Pharm Bull (Tokyo); 1971 Mar; 19(3):478-86. PubMed ID: 5553047
    [No Abstract]   [Full Text] [Related]  

  • 13. [Toxicity of 5-n-butyl-1-cyclohexyl-2,4,6-trioxoperhydropyrimidine (BCP)].
    Tanabe K; Takaori S; Shimamoto K
    Nihon Yakurigaku Zasshi; 1967 May; 63(3):105-22. PubMed ID: 6069762
    [No Abstract]   [Full Text] [Related]  

  • 14. [Correlation of resistance of Staphylococcus aureus and Klebsiella friedlender to monomycin in vitro and in vivo].
    Dratvin SA
    Antibiotiki; 1966 Jun; 11(6):552-7. PubMed ID: 4871258
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antibacterial in vitro and in vivo activity of a new tetracycline: CL 59806].
    Renzini G; Bevilacqua RL; Boemi G; Ravagnan L
    Antibiotica; 1967 Dec; 5(4):241-61. PubMed ID: 4900571
    [No Abstract]   [Full Text] [Related]  

  • 16. [In vivo antibacterial activity of an antibiotic association and its components].
    Bernardi F; Liani M; Ricci P
    Antibiotica; 1969 Dec; 7(4):269-74. PubMed ID: 5407462
    [No Abstract]   [Full Text] [Related]  

  • 17. Perspective. Hospital-acquired infections: the problems of methicillin-resistant Staphylococcus aureus and infections with Klebsiella pneumoniae.
    Finland M
    Am J Med Sci; 1972 Sep; 264(3):207-11. PubMed ID: 4486504
    [No Abstract]   [Full Text] [Related]  

  • 18. Antibacterial activity of human neutrophil defensins in experimental infections in mice is accompanied by increased leukocyte accumulation.
    Welling MM; Hiemstra PS; van den Barselaar MT; Paulusma-Annema A; Nibbering PH; Pauwels EK; Calame W
    J Clin Invest; 1998 Oct; 102(8):1583-90. PubMed ID: 9788972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experimental study of aeorsol elemorphocycline].
    Lagert IK; Poliak MS
    Antibiotiki; 1970 Jun; 15(6):554-7. PubMed ID: 5460172
    [No Abstract]   [Full Text] [Related]  

  • 20. A 3-year study of neonatal nosocomial infections in Alexandra Hospital 1982-1984.
    Tan KW
    J Singapore Paediatr Soc; 1986; 28(1-2):126-35. PubMed ID: 3762072
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.